Story
Unicaja Chairman José Sevilla Announces Plan to Step Down
Summary
The non-executive chairman of Spain's sixth-largest bank will not seek reelection following the next shareholder meeting, initiating a leadership succession process.
Unicaja's non-executive Chairman, José Sevilla, will step down following the company's next shareholder meeting, the Spanish lender announced on Thursday. Sevilla has indicated he will not seek reelection for his position.
Leadership Transition
In a statement, Unicaja said the early announcement of Sevilla's departure is intended to allow the succession process to proceed in an "appropriate and orderly manner." Sevilla was appointed non-executive chairman in February 2024 and officially assumed the role in April of that year.
The departure marks a significant leadership change for Unicaja, which ranks as Spain’s sixth-largest bank by market capitalization. Investors will be closely watching for the board's nomination of a successor and any potential implications for the bank's strategic direction.
AdChairman's Background
Prior to joining Unicaja, Sevilla had a long and prominent career in the Spanish banking sector. He served as the Chief Executive Officer of Bankia for nearly seven years.
His tenure at Bankia concluded after CaixaBank completed its acquisition of the former state-owned lender in March 2021, a landmark deal in the consolidation of Spain's financial industry.
Read next
More on Stocks
Portugal's PSI Index Falls Nearly 2% as Financials and Utilities Weigh
Portugal's benchmark PSI stock index closed down 1.97% on Thursday, dragged lower by significant losses in the financial and utilities sectors. Banco Comercial Portugues was among the session's biggest decliners, falling over 4%.
Morgan Stanley Initiates Homebuilders with Cautious View, Taps Toll Brothers as Sole 'Buy'
The investment bank cited affordability and margin pressures in its new coverage, giving luxury builder Toll Brothers its only 'Overweight' rating while starting Lennar and NVR at 'Underweight'.
Florida Sues Pfizer Over COVID-19 Vaccine Safety and Efficacy Claims
The state of Florida has filed a lawsuit against Pfizer and its CEO, alleging the company misled the public about its COVID-19 vaccine's safety, effectiveness, and ability to prevent transmission.
Florida Sues Pfizer, CEO Over COVID-19 Vaccine Safety and Efficacy Claims
Florida's attorney general has filed a lawsuit against Pfizer and CEO Albert Bourla, alleging the drugmaker misled consumers about its COVID-19 vaccine's safety, effectiveness, and pricing.